Skip to Main Content

Paper Details

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19.
Ann Clin Transl Neurol
46
2022
COVID-19, PASC, SARS-CoV-2, cognitive symptoms, participants
Author NameAffiliation
Timothy J HenrichUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Jeffrey N MartinUniversity of California san francisco
Bruce L MillerUniversity of California san francisco
Bruce L MillerWeill Institute for Neurosciences, University of California san francisco
Melanie L StephensUniversity of California san francisco
Melanie L StephensWeill Institute for Neurosciences, University of California san francisco
  • 1 - 8

Datasets

Release 1.2